Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,295 | Dovepress* | 5,458+ | 938 | 6,396 | |
| PubMed Central* | 1,837 | 311 | 2,148 | ||
| Totals | 7,295 | 1,249 | 8,544 | ||
| *Since 24 September 2020 | |||||
View citations on PubMed Central and Google Scholar